CN108720897B - Combination wave therapy device and therapy system - Google Patents
Combination wave therapy device and therapy system Download PDFInfo
- Publication number
- CN108720897B CN108720897B CN201810741583.1A CN201810741583A CN108720897B CN 108720897 B CN108720897 B CN 108720897B CN 201810741583 A CN201810741583 A CN 201810741583A CN 108720897 B CN108720897 B CN 108720897B
- Authority
- CN
- China
- Prior art keywords
- wave
- therapeutic
- combination
- treatment
- waves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 50
- 230000035939 shock Effects 0.000 claims abstract description 91
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 90
- 238000011282 treatment Methods 0.000 claims abstract description 81
- 238000002604 ultrasonography Methods 0.000 claims description 36
- 239000000523 sample Substances 0.000 claims description 35
- 230000007246 mechanism Effects 0.000 claims description 10
- 238000011269 treatment regimen Methods 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 210000001519 tissue Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 210000000130 stem cell Anatomy 0.000 description 7
- 238000009210 therapy by ultrasound Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- VDABVNMGKGUPEY-UHFFFAOYSA-N 6-carboxyfluorescein succinimidyl ester Chemical compound C=1C(O)=CC=C2C=1OC1=CC(O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O VDABVNMGKGUPEY-UHFFFAOYSA-N 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002648 combination therapy Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- IPJDHSYCSQAODE-UHFFFAOYSA-N 5-chloromethylfluorescein diacetate Chemical compound O1C(=O)C2=CC(CCl)=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 IPJDHSYCSQAODE-UHFFFAOYSA-N 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/225—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0245—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B2017/22005—Effects, e.g. on tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B2017/22005—Effects, e.g. on tissue
- A61B2017/22011—Combined types of vibration, e.g. ultrasonic and electrohydraulic
Abstract
The application relates to a combination wave treatment device and a treatment system. The combination wave therapy device includes: an ultrasonic wave generation unit (10) for generating therapeutic ultrasonic waves; a shock wave generating unit (20) for generating therapeutic shock waves; and a combined wave generator (30) coupled to the ultrasonic wave generation unit (10) and the shock wave generation unit (20), respectively, for combining the therapeutic ultrasonic wave and the therapeutic shock wave into a combined wave and applying the combined wave to a site to be treated. The application can improve the treatment effect and reduce the side effect of the treatment wave.
Description
Technical Field
The application relates to the field of medical equipment, in particular to combined wave treatment equipment and a treatment system.
Background
Therapeutic ultrasound is an ultrasound wave that transmits sonic energy to a target tissue to cause a variety of biological effects. As a form of mechanical energy for pressure waves, therapeutic ultrasound can act on human tissue to create micromechanical pressure and cause biochemical changes at the cellular and molecular level. At present, therapeutic ultrasound is mainly applied to the medical fields of tissue healing, nerve/muscle cell regeneration, and promoting cardiac vascular regeneration.
Therapeutic shock waves are a non-invasive treatment method, similar to ultrasound waves, with pressure effects, tension effects and cavitation effects. Therapeutic shock waves can pass through body fluids and tissues to reach affected parts, and different mechanical stresses can be generated at interfaces of different acoustic impedance tissues according to different mediums contacted in human bodies, such as soft tissues such as fat, tendon, ligament and the like, bone tissues and the like, and the mechanical stresses are represented by tensile stresses and compressive stresses generated on the tissues. In addition, the negative wave band at the tail of the pulse of the therapeutic shock wave can also cause cavitation effect, and can be used for dredging occluded micro-blood vessels and loosening the adhesion of joint soft tissues. Currently, therapeutic shock waves are mainly used in the treatment of calculi, pain and bone diseases.
Through the research of the inventor, the two treatment technologies have certain limitations and side effects. The sonic energy of ultrasound waves may cause local temperature increases, thereby adversely affecting the activity of some enzymes in the human body. Cavitation effects of ultrasound and shock waves may damage tissue cell integrity, causing damage to capillaries of the tissue, thereby causing bleeding, scarring, and even nerve damage.
Disclosure of Invention
The application aims to provide a combined wave treatment device and a treatment system, which can improve the treatment effect and reduce the side effect of treatment waves.
To achieve the above object, the present application provides a combination wave therapy apparatus comprising:
an ultrasonic wave generating unit for generating therapeutic ultrasonic waves;
a shock wave generating unit for generating therapeutic shock waves; and
and a combined wave generator coupled to the ultrasonic wave generation unit and the shock wave generation unit, respectively, for combining the therapeutic ultrasonic wave and the therapeutic shock wave into a combined wave and applying the combined wave to a site to be treated.
Further, the therapeutic ultrasound is a low energy pulsed ultrasound.
Further, the ultrasonic frequency range of the low-energy pulse ultrasonic wave is 1-2 MHz, and the sound intensity range is 0.05-3W/cm 2 。
Further, the ultrasonic frequency range of the low-energy pulse ultrasonic wave is 1.5-1.7 MHz.
Further, the therapeutic shock wave is a low intensity extracorporeal shock wave.
Further, the frequency range of the low-intensity external shock wave is 1-6 Hz, and the energy range is 0.01-0.7 mJ/mm 2 。
Further, the combined wave is a therapeutic shock wave and a therapeutic ultrasonic wave combined along a time sequence.
Further, the method further comprises the following steps:
and the controller is respectively connected with the ultrasonic wave generating unit, the shock wave generating unit and the combined wave generator in a signal way and is used for respectively adjusting the parameters of the therapeutic ultrasonic wave, the parameters of the therapeutic shock wave or the synthetic parameters of the combined wave.
Further, the medical treatment device also comprises a treatment probe and a probe adjusting mechanism, wherein the combined wave generator is arranged at the top end of the treatment probe, and the probe adjusting mechanism is operably coupled with the treatment probe and is used for adjusting the pose of the treatment probe.
Further, the probe adjusting mechanism comprises a mechanical arm, the treatment probe is mounted at the end part of the mechanical arm, the combined wave treatment equipment further comprises a controller, and the controller is respectively connected with the mechanical arm and the treatment probe in a signal manner and used for controlling the mechanical arm to drive the treatment probe to move to a part to be treated.
Further, the ultrasonic wave generating unit further comprises a first adjusting lens which is connected with the controller in a signal manner and used for adjusting the type of therapeutic ultrasonic wave output by the ultrasonic wave generating unit to the combined wave generator.
Further, the shock wave generating unit further comprises a second adjusting lens in signal connection with the controller for adjusting the type of therapeutic shock wave output by the shock wave generating unit to the combined wave generator.
Further, the type includes one of a plane wave, a dispersive wave, a focused wave, and a semi-focused wave.
Further, the method further comprises the following steps:
and the multimedia playing unit is in signal connection with the controller and is used for playing audio and video information of auxiliary use and/or auxiliary treatment.
To achieve the above object, the present application also provides a therapeutic system comprising:
the aforementioned combination wave therapy device; and
and the network cloud platform is in communication connection with the combination wave treatment equipment and is used for providing a treatment scheme for the combination wave treatment equipment.
Further, the network cloud platform includes:
the information storage unit is used for storing the identity identification information and medical record information of the patient;
a regimen storage unit for storing treatment regimens corresponding to different diseases and/or different patients;
and the scheme issuing unit is used for issuing a corresponding treatment scheme to the combined wave treatment equipment associated with the patient according to the downloading request from the patient terminal after confirming the identity identification information of the patient.
Further, the treatment regimen includes the site to be treated, parameters of the therapeutic ultrasound waves, parameters of the therapeutic shock waves, and parameters of the combination waves.
Based on the technical scheme, the therapeutic ultrasonic wave generated by the ultrasonic wave generating unit and the therapeutic shock wave generated by the shock wave generating unit are combined into the combined wave through the combined wave generator, and the combined wave is applied to the part to be treated for treatment, so that the biological curative effects of the therapeutic ultrasonic wave and the shock wave generating unit can be fully utilized during treatment, the treatment effect is improved, the energy required by the therapeutic ultrasonic wave and the therapeutic shock wave is respectively reduced, and the side effect of the therapeutic ultrasonic wave or the therapeutic shock wave with higher energy is reduced or avoided.
Drawings
The accompanying drawings, which are included to provide a further understanding of the application and are incorporated in and constitute a part of this specification, illustrate embodiments of the application and together with the description serve to explain the application and do not constitute a limitation on the application. In the drawings:
fig. 1 is a block schematic diagram of an embodiment of a combination wave therapy device of the present application.
Fig. 2 is a block schematic diagram of another embodiment of a combination wave therapy device of the present application.
Fig. 3 is a block schematic diagram of a further embodiment of a combination wave therapy device of the present application.
Fig. 4 is a block diagram of an embodiment of the treatment system of the present application.
FIG. 5 is a graph comparing the results of four sets of adipose-derived stem cell proliferation assays.
Fig. 6-8 are graphs comparing the results of four sets of adipose-derived stem cell activation assays at 40-fold, 100-fold and 200-fold.
Fig. 9 (a) and 9 (b) are graphs comparing the EdU incorporation efficiency and the cell mitosis ratio of four sets of fatty liver cell activation assays, respectively.
Detailed Description
The technical scheme of the application is further described in detail through the drawings and the embodiments.
Fig. 1 is a block diagram schematically illustrating an embodiment of the combination wave therapy device of the present application. In this embodiment, the combination wave therapy device includes: an ultrasonic wave generation unit 10, a shock wave generation unit 20, and a combination wave generator 30. The ultrasonic wave generating unit 10 is used for generating therapeutic ultrasonic waves, and the therapeutic ultrasonic waves are preferably low-energy pulse ultrasonic waves for obtaining a better therapeutic effect. The shock wave generating unit 20 is used for generating therapeutic shock waves, and the therapeutic shock waves preferably use low-intensity external shock waves for better therapeutic effects. For convenience of use, the combination wave therapy device may have a main body, and the ultrasonic wave generation unit 10 and the shock wave generation unit 20 may be disposed inside a cabinet of the main body. A combination wave generator 30 is coupled to the ultrasonic wave generation unit 10 and the shock wave generation unit 20, respectively, for combining the therapeutic ultrasonic wave and the therapeutic shock wave into a combination wave and applying the combination wave to a site to be treated. The combined wave generator 30 may be disposed outside the chassis of the host. An interface for user interaction and the like can be arranged in the case of the host.
The therapeutic ultrasonic wave generated by the ultrasonic wave generating unit and the therapeutic shock wave generated by the shock wave generating unit are combined into the combined wave through the combined wave generator, and the combined wave is applied to the part to be treated for treatment, so that the biological curative effects of the therapeutic ultrasonic wave and the shock wave generating unit can be fully utilized during treatment, the treatment effect is improved, the energy required by the therapeutic ultrasonic wave and the therapeutic shock wave is respectively reduced, and the side effect of the therapeutic ultrasonic wave or the therapeutic shock wave with higher energy is reduced or avoided.
Referring to fig. 5, the therapeutic effects of therapeutic ultrasound and therapeutic shock waves have been mentioned in the background, and it is mentioned that tissue damage may result when the energy level of the ultrasound or shock waves is too high. The inventors have employed a combination of sequential application of low energy pulsed ultrasound with low intensity external shock waves in an effort to explore better therapeutic effects and fewer side effects.
To perform an effect control, the inventors divided adipose stem cells into four groups: control group (ctrl), low energy pulsed ultrasound treatment group (LIPUS), low intensity external shock wave treatment group (Li-ESWT), and low energy pulsed ultrasound and low intensity external shock waveCombination therapy (US-SW). Wherein, the low-energy pulse ultrasonic treatment group adopts 60mW/cm 2 Two minutes, the low-intensity external shock wave group adopts 0.02mJ/mm 2 3Hz,200pulses. The low energy pulsed ultrasound and low intensity external shock wave combination therapy group first employs Li-ESWT0.02mJ/mm2,3Hz,100pulses, and then delivers low energy pulsed ultrasound LIPUS60mW/cm 2 One minute.
5-chloromethylfluorescein diacetate (CFDA for short) has cell membrane permeability and does not have fluorescence. After penetrating the cell membrane into living cells by passive transport, carboxyfluorescein succinimidyl ester (carboxyfluorescein succinimidyl ester, CFSE) is produced by intracellular esterase catalysis, which can fluoresce strongly green, cannot penetrate the cell membrane, and can remain intact in the cell. Viable cells in the petri dishes were labeled with 10uM CFDA. Fluorescence microscopy was then used for photography and image analysis. Combining the images shown in fig. 5 with active cells/high power cell/HPF, it can be seen that both the low energy pulsed ultrasound treatment group and the low intensity in vitro shock wave group significantly promote cell proliferation and increase cell number compared to the control group. The combined treatment group of half low-energy pulse ultrasonic waves and low-intensity external shock waves can achieve stronger effects, and the synergistic effect of therapeutic ultrasonic waves and therapeutic shock waves is reflected. Based on the lower applied energy of ultrasonic wave and shock wave, the combination has less damage to tissues and can achieve stronger treatment effect.
Referring now to FIGS. 6-9 (b), the EdU incorporation assay was used to monitor the activation of stem cells by low energy pulsed ultrasound and low intensity in vitro shock waves and to detect the expression of the cell division marker H3P. To perform an effect control, the inventors divided adipose stem cells into four groups: control group (ctrl), low energy pulsed ultrasound treatment group (LIPUS), low intensity external shock wave treatment group (Li-ESWT) and low energy pulsed ultrasound combined with low intensity external shock wave treatment group (US-SW). Wherein, the low-energy pulse ultrasonic treatment group adopts 60mW/cm 2 Two minutes, the low-intensity external shock wave group adopts 0.02mJ/mm 2 ，3Hz，200pulses. The low energy pulsed ultrasound and low intensity external shock wave combination therapy group was first treated with Li-ESWT0.02mJ/mm2,3Hz,100pulses, and then low energy pulsed ultrasound LIPUS60mW/cm was administered 2 One minute. Immediately after treatment, 10uM EdU was added to each group for 6 hours of incubation, followed by replacement of the conventional cell culture broth. After 24 hours the expression of EdU and the expression of H3P were examined.
Combining the images of different multiples shown in fig. 6-8, it can be seen that both the low energy pulsed ultrasound treatment group and the low intensity in vitro shock wave group are able to significantly increase the incorporation efficiency of EdU compared to the control group, indicating that both can promote S-phase DNA synthesis by stem cells. The combined treatment group of half low-energy pulse ultrasonic waves and low-intensity external shock waves can achieve stronger effects, and the synergistic effect of therapeutic ultrasonic waves and therapeutic shock waves is reflected. In addition, the stem cell mitosis can be remarkably improved whether the low-energy pulse ultrasonic treatment group and the low-intensity external shock wave treatment group or the combined treatment group of half-amount of low-energy pulse ultrasonic waves and low-intensity external shock waves are adopted respectively. Based on the lower applied energy of ultrasonic wave and shock wave, the combination has less damage to tissues and can achieve stronger treatment effect.
The organism stimulation mode of the combined treatment group can promote tissue regeneration and healing, and can be used for treating various diseases, such as male erectile dysfunction, urinary incontinence, postpartum recovery of women, and the like.
In the above embodiment, the ultrasonic frequency range of the low-energy pulse ultrasonic wave is preferably 1 to 2MHz, and the sound intensity range is 0.05 to 3W/cm 2 . More preferably, the ultrasonic frequency of the low-energy pulsed ultrasonic wave ranges from 1.5 to 1.7MHz. Thus, the low-energy pulse ultrasonic waves can obtain better treatment effect with lower energy and reduce damage to tissues. The frequency range of the low-intensity external shock wave is preferably 1-6 Hz, and the energy range is 0.01-0.7 mJ/mm 2 . Thus, the low-intensity in-vitro ultrasonic waves can obtain better treatment effect with lower energy and reduce the damage to tissues.
Referring to fig. 1, the combined wave generator 30 may employ a therapeutic shock wave and a therapeutic ultrasonic wave, which are combined in time series, as the combined wave when the combined wave is applied to the treatment site. In other embodiments, the therapeutic shock wave and therapeutic ultrasound wave may be applied simultaneously or in multiple alternating ways or in different orders depending on the therapeutic needs.
Fig. 2 is a block diagram schematically illustrating another embodiment of the combination wave therapy device of the present application. Compared to the previous embodiment, the combination wave therapy device further includes a controller 60. The controller 60 is respectively signal-connected to the ultrasonic wave generating unit 10, the shock wave generating unit 20 and the combined wave generator 30, and is used for respectively adjusting the parameters of the therapeutic ultrasonic wave, the parameters of the therapeutic shock wave or the combined wave. The parameters of the therapeutic ultrasound waves here may include the ultrasound frequency range, the sound intensity range, the type of therapeutic ultrasound waves, etc. Parameters of the therapeutic shock wave may include frequency range, energy range, type of therapeutic shock wave, and the like. The composite parameters of the combined wave may include the duration of time the therapeutic ultrasound wave is applied, the number of pulses of the therapeutic shock wave, the timing relationship of the application of the two waves, and so forth.
To adjust the type of therapeutic ultrasound, in some embodiments, the ultrasound generating unit 10 may further include a first adjustment lens in signal communication with the controller 60 for adjusting the type of therapeutic ultrasound output by the ultrasound generating unit 10 to the combination wave generator 30. Similarly, to adjust the type of therapeutic shock wave, in some embodiments, the shock wave generating unit 20 may further include a second adjusting lens in signal connection with the controller 60 for adjusting the type of therapeutic shock wave output by the shock wave generating unit 20 to the combined wave generator 30. The type herein may include one of a plane wave, a dispersive wave, a focused wave, and a semi-focused wave according to a focusing manner of the wave.
These types of waves are manifestations of the wave as it emanates and are distinguished primarily from the density of the wave. Wherein plane waves are all beams which are parallel and are not focused nor diverged; the scattered wave is that the wave beam is divergent, and the wave density is smaller than the plane wave; the beam of the focused wave is converged on a focus, so that the energy is more concentrated, and the wave density is higher; a semi-focused wave is a wave between a focused wave and a plane wave in terms of wave density, and relatively speaking, the wave density is also between the two, and is larger than the plane wave and smaller than the focused wave. The first adjusting lens and the second adjusting lens can adopt acoustic lenses to change the focusing degree of ultrasonic waves or shock waves, and change the energy concentration degree by changing different focusing types so as to obtain different treatment effects.
In order to facilitate the use of the combination wave therapy device of the present application by a user, a multimedia play unit 70 may also be included in the combination wave therapy device. The multimedia playing unit 70 is in signal connection with the controller 60, and is used for playing audio and video information of auxiliary use and/or auxiliary treatment. The multimedia playing unit 70 may be an upper computer communicatively connected to the main unit of the combination wave therapy device, a display, a sound card, etc. on the main unit of the combination wave therapy device, or a headset, etc. that may be worn on the head of the user. The multimedia playing unit 70 may inform the user of the usage of the combination wave therapy device in an audio-visual manner, and provide music, pictures, white noise, etc. that may assist in therapy when some therapy is provided.
Fig. 3 is a block schematic diagram of a further embodiment of the combination wave therapy device of the present application. The combination wave therapy device of the present embodiment may further include a therapy probe 40 and a probe adjustment mechanism 50, as compared to the previous embodiments. A combination wave generator 30 may be disposed on top of the treatment probe 40, with the probe adjustment mechanism 50 operatively coupled to the treatment probe 40. The user can hold the treatment probe 40 to aim the top end of the treatment probe 40 at the treatment part to treat, or adjust the pose, namely the movement position and the emission angle, of the treatment probe 40 through the probe adjusting mechanism 50, so that the treatment probe 40 can be more accurately and conveniently aimed at the treatment part, and a better treatment effect is obtained.
The probe adjusting mechanism 50 comprises a mechanical arm, the treatment probe 40 is mounted at the end part of the mechanical arm, the combined wave treatment device further comprises a controller 60, and the controller 60 is respectively connected with the mechanical arm and the treatment probe 40 in a signal manner and is used for controlling the mechanical arm to drive the treatment probe 40 to move to a treatment part. The controller 60 can control the mechanical arm to move according to a preset instruction or an instruction from the local or network side of the user, and drive the treatment probe 40 to move among a plurality of treatment sites.
The combined wave treatment equipment can be used offline in a user family or a medical place, and can also be used for carrying out information interaction with a network cloud platform online. Fig. 4 is a block diagram of an embodiment of the treatment system of the present application. In this embodiment, the treatment system includes any of the combination wave treatment device embodiments described previously and a network cloud platform 80. A network cloud platform 80 is communicatively coupled to the combination wave therapy device for providing a therapy regimen to the combination wave therapy device. Referring to fig. 4, in some embodiments, the network cloud platform 80 may specifically include: an information storage unit 81, a scenario storage unit 82, and a scenario issuing unit 83. The information storage unit 81 is used for storing identification information and medical record information of a patient. The regimen storage unit 82 is used to store treatment regimens corresponding to different diseases and/or different patients. The treatment regimen may include the site to be treated, parameters of the therapeutic ultrasound waves, parameters of the therapeutic shock waves, and parameters of the combination waves. The plan issuing unit 83 is configured to issue a corresponding treatment plan to a combination wave treatment device associated with a patient according to a download request from a patient terminal after confirming identification information of the patient. The patient terminal may be a mobile or fixed terminal that the patient uses by himself or may be an operable interface provided on the combination wave therapy device.
Finally, it should be noted that the above-mentioned embodiments are only for illustrating the technical scheme of the present application and are not limiting; while the application has been described in detail with reference to the preferred embodiments, those skilled in the art will appreciate that: modifications may be made to the specific embodiments of the present application or equivalents may be substituted for part of the technical features thereof; without departing from the spirit of the application, it is intended to cover the scope of the application as claimed.
Claims (13)
1. A combination wave therapy device, comprising:
an ultrasonic wave generation unit (10) for generating therapeutic ultrasonic waves;
a shock wave generating unit (20) for generating therapeutic shock waves; and
a combined wave generator (30) coupled to the ultrasonic wave generation unit (10) and the shock wave generation unit (20), respectively, for combining the therapeutic ultrasonic wave and the therapeutic shock wave into a combined wave and applying the combined wave to a site to be treated;
wherein the therapeutic ultrasound is a low energy pulsed ultrasound; the ultrasonic frequency range of the low-energy pulse ultrasonic wave is 1-2 MHz, and the sound intensity range is 0.05-3W/cm 2 The method comprises the steps of carrying out a first treatment on the surface of the The therapeutic shock wave is a low-intensity external shock wave, the frequency range of the low-intensity external shock wave is 1-6 Hz, and the energy range is 0.01-0.7 mJ/mm 2 。
2. The combination wave therapy device according to claim 1, wherein the ultrasonic frequency range of the low-energy pulsed ultrasonic waves is 1.5 to 1.7MHz.
3. The combination wave therapy device according to claim 1, wherein the combination wave is a therapeutic shock wave and a therapeutic ultrasonic wave combined in time series.
4. The combination wave therapy device of claim 3, further comprising:
and the controller (60) is respectively connected with the ultrasonic wave generating unit (10), the shock wave generating unit (20) and the combined wave generator (30) in a signal mode and is used for respectively adjusting the parameters of the therapeutic ultrasonic wave, the parameters of the therapeutic shock wave or the synthetic parameters of the combined wave.
5. The combination wave therapy device according to claim 1, further comprising a therapy probe (40) and a probe adjustment mechanism (50), the combination wave generator (30) being disposed at a tip of the therapy probe (40), the probe adjustment mechanism (50) being operatively coupled with the therapy probe (40) for adjusting a pose of the therapy probe (40).
6. The combination wave therapy device according to claim 5, characterized in that the probe adjustment mechanism (50) comprises a mechanical arm, the therapy probe (40) is mounted at the end of the mechanical arm, the combination wave therapy device further comprises a controller (60), and the controller (60) is respectively connected with the mechanical arm and the therapy probe (40) in a signal manner and is used for controlling the mechanical arm to drive the therapy probe (40) to move to a to-be-treated part.
7. The combination wave therapy device according to claim 4, characterized in that the ultrasound generating unit (10) further comprises a first adjustment lens in signal connection with the controller (60) for adjusting the type of therapeutic ultrasound outputted by the ultrasound generating unit (10) to the combination wave generator (30).
8. The combination wave therapy device according to claim 4, characterized in that the shock wave generating unit (20) further comprises a second adjustment lens in signal connection with the controller (60) for adjusting the type of therapeutic shock wave output by the shock wave generating unit (20) to the combination wave generator (30).
9. The combination wave therapy device of claim 7 or 8, wherein the type comprises one of plane waves, dispersive waves, focused waves, and semi-focused waves.
10. The combination wave therapy device of claim 4, further comprising:
and the multimedia playing unit (70) is in signal connection with the controller (60) and is used for playing the audio and video information of auxiliary use and/or auxiliary treatment.
11. A therapeutic system, comprising:
the combination wave therapy device of any one of claims 1 to 10; and
and the network cloud platform (80) is in communication connection with the combination wave treatment device and is used for providing a treatment scheme for the combination wave treatment device.
12. The therapy system of claim 11, wherein the network cloud platform (80) comprises:
an information storage unit (81) for storing identification information and medical record information of a patient;
a regimen storage unit (82) for storing treatment regimens corresponding to different diseases and/or different patients;
and the scheme issuing unit (83) is used for issuing a corresponding treatment scheme to the combined wave treatment equipment associated with the patient according to the downloading request from the patient terminal after confirming the identification information of the patient.
13. The treatment system of claim 12, wherein the treatment regimen comprises a site to be treated, parameters of the therapeutic ultrasound waves, parameters of the therapeutic shock waves, and parameters of the composite waves.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810741583.1A CN108720897B (en) | 2018-07-09 | 2018-07-09 | Combination wave therapy device and therapy system |
| PCT/CN2019/095101 WO2020011130A1 (en) | 2018-07-09 | 2019-07-08 | Combination wave-based therapeutic apparatus and system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810741583.1A CN108720897B (en) | 2018-07-09 | 2018-07-09 | Combination wave therapy device and therapy system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108720897A CN108720897A (en) | 2018-11-02 |
| CN108720897B true CN108720897B (en) | 2023-12-05 |
Family
ID=63925948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810741583.1A Active CN108720897B (en) | 2018-07-09 | 2018-07-09 | Combination wave therapy device and therapy system |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN108720897B (en) |
| WO (1) | WO2020011130A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108744322B (en) * | 2018-07-09 | 2024-03-29 | 北京万孛力医疗器械有限公司 | Treatment equipment for asthenozoospermia |
| CN108720897B (en) * | 2018-07-09 | 2023-12-05 | 北京万孛力医疗器械有限公司 | Combination wave therapy device and therapy system |
| EP3682822B1 (en) * | 2019-01-18 | 2024-05-08 | Storz Medical AG | Combined shockwave and ultrasound source |
| CN114259279B (en) * | 2021-12-22 | 2024-03-19 | 深圳市慧康精密仪器有限公司 | Therapeutic device capable of generating shock wave or ultrasonic wave |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4976255A (en) * | 1988-08-17 | 1990-12-11 | Siemens Aktiengesellschaft | Apparatus for extracorporeal lithotripsy using shock waves and therapeutic ultrasound |
| CN2514847Y (en) * | 1999-09-28 | 2002-10-09 | 玉骑 | Composite pulse generator for electric pulse beautifying device |
| CN101437459A (en) * | 2006-05-05 | 2009-05-20 | 西门子公司 | Shock wave head for a shock wave treatment apparatus and method for the fragmentation of and for controlling the fragmentation of a fragmentation object arranged in an object under investigation |
| KR20090117208A (en) * | 2008-05-09 | 2009-11-12 | 주식회사 에이치엔티메디칼 | Shock wave and ultrasound wave integrated therapy device |
| CN104138638A (en) * | 2014-07-15 | 2014-11-12 | 深圳市慧康精密仪器有限公司 | Erectile dysfunction impact wave therapeutic instrument |
| CN105726190A (en) * | 2014-12-12 | 2016-07-06 | 北京东方百奥医药开发有限公司 | Pulse ultrasound treatment equipment for male erectile dysfunction |
| CN107301321A (en) * | 2017-07-14 | 2017-10-27 | 安徽荣旭信息科技有限公司 | A kind of Multifunctional medical information network system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7048699B2 (en) * | 2001-09-12 | 2006-05-23 | Moshe Ein-Gal | Non-cylindrical acoustic wave device |
| US7601127B2 (en) * | 2004-10-22 | 2009-10-13 | General Patent, Llc | Therapeutic stimulation of genital tissue or reproductive organ of an infertility or impotence diagnosed patient |
| US20110144544A1 (en) * | 2009-12-15 | 2011-06-16 | General Electric Company | Ultrasound transducer assembly and methods of using |
| JP5945540B2 (en) * | 2010-08-27 | 2016-07-05 | シエナ バイオファーマシューティカルズ，インク． | Compositions and methods for targeted thermal modulation |
| WO2015138781A1 (en) * | 2014-03-12 | 2015-09-17 | The Regents Of The University Of Michigan | Frequency compounding ultrasound pulses for imaging and therapy |
| CN205885491U (en) * | 2016-06-21 | 2017-01-18 | 深圳市慧康精密仪器有限公司 | External heart shock wave therapy apparatus |
| CN108720897B (en) * | 2018-07-09 | 2023-12-05 | 北京万孛力医疗器械有限公司 | Combination wave therapy device and therapy system |
-
2018
- 2018-07-09 CN CN201810741583.1A patent/CN108720897B/en active Active
-
2019
- 2019-07-08 WO PCT/CN2019/095101 patent/WO2020011130A1/en active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4976255A (en) * | 1988-08-17 | 1990-12-11 | Siemens Aktiengesellschaft | Apparatus for extracorporeal lithotripsy using shock waves and therapeutic ultrasound |
| CN2514847Y (en) * | 1999-09-28 | 2002-10-09 | 玉骑 | Composite pulse generator for electric pulse beautifying device |
| CN101437459A (en) * | 2006-05-05 | 2009-05-20 | 西门子公司 | Shock wave head for a shock wave treatment apparatus and method for the fragmentation of and for controlling the fragmentation of a fragmentation object arranged in an object under investigation |
| KR20090117208A (en) * | 2008-05-09 | 2009-11-12 | 주식회사 에이치엔티메디칼 | Shock wave and ultrasound wave integrated therapy device |
| CN104138638A (en) * | 2014-07-15 | 2014-11-12 | 深圳市慧康精密仪器有限公司 | Erectile dysfunction impact wave therapeutic instrument |
| CN105726190A (en) * | 2014-12-12 | 2016-07-06 | 北京东方百奥医药开发有限公司 | Pulse ultrasound treatment equipment for male erectile dysfunction |
| CN107301321A (en) * | 2017-07-14 | 2017-10-27 | 安徽荣旭信息科技有限公司 | A kind of Multifunctional medical information network system |
Non-Patent Citations (2)
| Title |
|---|
| Clinical applications of low-intensity pulsed ultrasound and its potential role in urology;辛钟成等;TRANSLATIONAL ANDROLOGY AND UROLOGY;第5卷(第2期);第255-266页 * |
| 低能量体外冲击波治疗的临床应用进展;辛钟成等;北京大学学报( 医学版);第45卷(第4期);第657-660页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108720897A (en) | 2018-11-02 |
| WO2020011130A1 (en) | 2020-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108720897B (en) | Combination wave therapy device and therapy system | |
| US20070065420A1 (en) | Ultrasound Therapy Resulting in Bone Marrow Rejuvenation | |
| US8512250B2 (en) | Component ultrasound transducer | |
| EP1711109B1 (en) | Localized production of microbubbles and control of cavitational and heating effects by use of enhanced ultrasound | |
| US8298163B1 (en) | Non-invasive ultrasonic soft-tissue treatment apparatus | |
| US7828734B2 (en) | Device for ultrasound monitored tissue treatment | |
| US7610079B2 (en) | Shock wave imaging system | |
| US20120165848A1 (en) | System and method for treating cartilage | |
| US20150165243A1 (en) | System and Method for Treating Cartilage and Injuries to Joints and Connective Tissue | |
| US20110251524A1 (en) | Device for ultrasound treatment and monitoring tissue treatment | |
| CN113195114A (en) | Ultrasonic device for use with synthetic cavitation nuclei | |
| JP2002537013A (en) | Method and apparatus for uniform transdermal therapeutic ultrasound | |
| US11857813B2 (en) | High intensity focused ultrasound systems for treating tissue | |
| Henderson et al. | A portable high-intensity focused ultrasound device for noninvasive venous ablation | |
| CN101068594A (en) | An ultrasonic equipment for treatment of osteoarthritis | |
| WO2010029556A1 (en) | A device for ultrasound treatment and monitoring tissue treatment | |
| FYFE et al. | Therapeutic ultrasound: some historical background and development in knowledge of its effect on healing | |
| CN108744322B (en) | Treatment equipment for asthenozoospermia | |
| US11583299B1 (en) | Noninvasive fragmentation of urinary tract stones with focused ultrasound | |
| CN212879470U (en) | Combined wave therapeutic equipment and therapeutic system | |
| US10130739B2 (en) | Flexible, ultrasound-coupled devices and methods for aspirating biological tissue | |
| Zharov et al. | Design and application of low-frequency ultrasound and its combination with laser radiation in surgery and therapy | |
| WO2023234231A1 (en) | Ultrasound therapy device for cardiac disease | |
| JP2016195618A (en) | DEVICE FOR TREATING A VASCULAR ENDOTHELIAL FUNCTION TROUBLE, AND ACTIVATION CONTROL METHOD OF PLCγ1, ERK5 OR ERK1/2 | |
| Mess et al. | Designing a Murine Model of Human Glioblastoma Brain Tumor: Development of a Platform for Validation Using Ultrasound Elastography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |